A small series of 6 newborns with seizures were followed in Seizure-European Journal of Epilepsy on Levetiracetam. All six patients treated with oral LEV became seizure free within 6 days. Five patients remained seizure free after 3 months with ongoing LEV monotherapy. One infant developed pharmacoresistent epilepsy. Seizures relapsed later in the clinical course of two more patients, one of whom was no longer under LEV therapy.
This drug is beginning to be used more often in neonatal population. We are now seeing some studies.
No comments:
Post a Comment